Trends and hotspots in familial hypercholesterolemia: A bibliometric systematic review from 2002 to 2022.

FH research has shown shows a trend of ascending followed by leveling off. The prevalence and diagnosis of FH, proprotein convertase subtilisin/kexin 9 inhibitors, inclisiran, and gene therapy are current research hotspots. This report may serve as a reference for current research trends.